5 Health Services Stocks Nudging The Industry Higher

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 31 points (0.2%) at 15,006 as of Tuesday, July 2, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,611 issues advancing vs. 1,325 declining with 103 unchanged.

The Health Services industry currently sits down 0.4% versus the S&P 500, which is up 0.4%. A company within the industry that increased today was Grifols ( GRFS), up 0.9%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. Zimmer Holdings ( ZMH) is one of the companies pushing the Health Services industry higher today. As of noon trading, Zimmer Holdings is up $0.93 (1.2%) to $75.93 on average volume. Thus far, 442,909 shares of Zimmer Holdings exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $75.00-$76.56 after having opened the day at $75.15 as compared to the previous trading day's close of $75.00.

Zimmer Holdings, Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of orthopedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. Zimmer Holdings has a market cap of $12.6 billion and is part of the health care sector. The company has a P/E ratio of 17.0, below the S&P 500 P/E ratio of 17.7. Shares are up 12.4% year to date as of the close of trading on Monday. Currently there are 11 analysts that rate Zimmer Holdings a buy, 1 analyst rates it a sell, and 16 rate it a hold.

TheStreet Ratings rates Zimmer Holdings as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Zimmer Holdings Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Zimmer Biomet's Prognosis Is Promising

Zimmer Biomet's Prognosis Is Promising

St. Jude Buying Thoratec Could Resusitate Medtech M&As

Analysts' Actions -- AT&T, Fitbit, Netflix and More

Barbarian At The Gate: Zimmer Holdings (ZMH)

Deal Delay Minor Obstacle for Zimmer

Deal Delay Minor Obstacle for Zimmer